A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with localized prostate cancer (PCa), there is a need for ...

Prostate cancer usually develops slowly, so there may be no signs of the health condition for many years, but once the tumour ...

My husband died aged 72 from prostate cancer. He used talcum powder daily for 50 years and I read recently that it was linked ...

Viewed as a ‘mini me’ version of the all-conquering Telix Pharmaceuticals, the $60 million market cap Radiopharm Theranostics ...

DEMENTIA will affect one in three of us in our lifetime. So it is no wonder that 54 per cent of Sun readers are worried about ...

This helpful list will equip you with the tools to navigate your health journey with confidence. Based in Harley Street, ...

If you’re confused about what a health insurance policy covers, you may be at financial risk. Or, you may assume that your ...

In this systematic review, ten studies reported risk reclassification of prostate cancer with genome classifier testing, with ...